Loading…
RCEL
AVITA Medical, Inc.
NASDAQ· Healthcare· Medical Devices· CUSIP 05380C102
$10.35+0.29%Price as of Aug 29, 18:33 UTC · updated once a day, after the close
Key metrics
- Market cap
- $320.09M
- P/E
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- —
- Payout
- —
- EPS
- -$1.44
- ROE
- —
- Profit margin
- -56.96%
- Revenue growth
- +17.80%
- Beta
- 1.85
- 52-week high
- $10.77
- 52-week low
- $3.22
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -28.1% over 5Y.
today you would have $668.17▼ -33.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $3.45 | $12.80 | $13.72 | $6.60 | $11.98 | $18.58 | $45.50 | $5.60 | |
| P/E | 9.0x | — | — | — | 6.2x | 10.2x | 9.0x | 29.2x | 4.1x |
| P/S | 8.6x | 1.5x | 5.3x | 7.0x | 4.9x | 10.2x |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| EYPTEyePoint, Inc. | $3.72 | — | 9.4x | — | -148.70% | $320.71M |
| VCREVicore Pharma Holding AB | $11.31 | — | — | — | -56.99% | $318.41M |
| SMTISanara MedTech Inc. | $34.57 | — | 45.1x | — | -1.32% | $317.63M |
| PRQRProQR Therapeutics N.V. | $2.29 |
About the company
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
- 226
- Valencia, United States
Company description provided by Yahoo Finance.